Efficacy of monoclonal antibodies against CGRP in migraine patients with fibromyalgia comorbidity: a retrospective monocentric observational study
We found that in migraine suffereres with FM, anti-CGRP monoclonal antibodies had a similar beneficial effect on migraine as in non-fibromyalgia patients, in addition to reducing somatic pain and global disability from the disease. The anti-CGRP agents, represent a good option for the treatment of migraineurs with fibromyalgia, for which no resolutive therapy is yet available.
Authors
- Livio Clemente (ORCID: https://orcid.org/0000-0001-5463-0460)
- G. Paparella (ORCID: https://orcid.org/0009-0007-2103-4276)
- Marina de Tommaso (ORCID: https://orcid.org/0000-0001-6567-5373)
- Stefania Scannicchio
- Giuseppe Libro
Institutions
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1186/s10194-025-02034-y
- Citations
- 3
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 4.41